hy, Sales of gastric health double formulation Will exceeded 1 million in about 10 days
Mar 25, 2025
hy's introduction on the 3rd reached 1 million sales in 10 days. hy It is a health functional food that focuses on technology, and consumers' choices are continuing with functionality and convenience of intake.
Will Peony is a product that combines the technology of gastric health research that hy has built up since the launch of 'Helicobacter Project Will'. With the brand's first double formulation design, tablets and liquids can be consumed at once. It is characterized by strengthening functionality by applying different individual recognized materials for gastric health depending on the formulation.
The tablet in the lid contained 'Composite such as Peony Extract'. Peony extract is a traditional material made by mixing peony roots and sunbokhwa. It can help stomach health by protecting the gastric mucosa. 100% meets the recommended daily intake of 700mg. The liquid phase is designed as a complex function so that the intestinal (腸) and stomach health can be taken care of together. It contains a variety of probiotics, including self-developed patented lactic acid bacteria 'HP7'. It can help intestinal health by guaranteeing 10 billion CFU. 100 mg of natural product material 'Cujipong leaf extract' was also added. The recommended daily intake can help improve stomach discomfort.
hy Representative brand 'Helicobacter Project Will' is the No. 1 product in domestic drink fermented oil sales with annual sales of 330 billion won, and has steadily increased marketability through 11 renewals since its launch. Earlier this month, it entered North America's largest Asian mart chain 'Hmart' and is speeding up its entry into the global market.
Meanwhile, hy is speeding up its market targeting as an original probiotic company. In particular, it is striving to expand the base of functional probiotics by strengthening its dual product lineup such as 'Coopers' and 'MPRO4'. Recently, it started production of capsule-type powder products 'BioLib' through facility expansion. Material B2B business is also cruising with lactobacillus 'kill pat'.
Will Peony is a product that combines the technology of gastric health research that hy has built up since the launch of 'Helicobacter Project Will'. With the brand's first double formulation design, tablets and liquids can be consumed at once. It is characterized by strengthening functionality by applying different individual recognized materials for gastric health depending on the formulation.
The tablet in the lid contained 'Composite such as Peony Extract'. Peony extract is a traditional material made by mixing peony roots and sunbokhwa. It can help stomach health by protecting the gastric mucosa. 100% meets the recommended daily intake of 700mg. The liquid phase is designed as a complex function so that the intestinal (腸) and stomach health can be taken care of together. It contains a variety of probiotics, including self-developed patented lactic acid bacteria 'HP7'. It can help intestinal health by guaranteeing 10 billion CFU. 100 mg of natural product material 'Cujipong leaf extract' was also added. The recommended daily intake can help improve stomach discomfort.
hy Representative brand 'Helicobacter Project Will' is the No. 1 product in domestic drink fermented oil sales with annual sales of 330 billion won, and has steadily increased marketability through 11 renewals since its launch. Earlier this month, it entered North America's largest Asian mart chain 'Hmart' and is speeding up its entry into the global market.
Meanwhile, hy is speeding up its market targeting as an original probiotic company. In particular, it is striving to expand the base of functional probiotics by strengthening its dual product lineup such as 'Coopers' and 'MPRO4'. Recently, it started production of capsule-type powder products 'BioLib' through facility expansion. Material B2B business is also cruising with lactobacillus 'kill pat'.
|
This article was translated by Naver AI translator.
